CBL 抗体 (AA 470-766)
Our Local Distributor
北京 101111
Quick Overview for CBL 抗体 (AA 470-766) (ABIN7875170)
抗原
See all CBL 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 470-766
-
原理
- CBL Antibody / Casitas B-lineage lymphoma proto-oncogene
-
纯化方法
- Antigen affinity purified
-
免疫原
- Recombinant human protein (amino acids M470-E766) was used as the immunogen for the CBL antibody.
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal dilution of the CBL antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
缓冲液
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
储存条件
- 4 °C,-20 °C
-
储存方法
- After reconstitution, the CBL antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))
-
别名
- CBL
-
背景
- CBL (Cbl proto-oncogene) is also known as C-CBL, RNF55, CBL2 and E3 ubiquitin-protein ligase CBL. CBL is mapped to chromosome 11q23.3-qter by molecular characterization of the breakpoints in 2 somatic cell hybrids. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes(E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder.
-
UniProt
- P22681
-
途径
- TCR Signaling, Interferon-gamma Pathway, EGFR Signaling Pathway, EGFR Downregulation, VEGFR1 Specific Signals
抗原
-